FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, genetic and protein engineering. Method for extraction and purification of recombinant protein, analogue of human kappa-casein fragment, involves cultivation of HEK293T-producing cells expressing recombinant EL1 protein, concentration and purification of the culture medium first using cation-exchange chromatography on SP-sepharose, and then using nickel-affinity chromatography on IMAC-sepharose, successive elution from impurity proteins and target product sorbents using a system of eight buffer solutions and subsequent purification of the end product by dialysis against 150 mM NaCl.
EFFECT: invention increases specific activity and purity of the end product.
1 cl, 7 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREPARATION OF RECOMBINANT ANTAGONIST OF HUMAN INTERLEUKINE-1 RECEPTOR "ARIL" | 2004 |
|
RU2326947C2 |
| METHOD OF EXTRACTION AND PURIFICATION OF RECOMBINANT HUMAN PROUROKINASE M5 | 2013 |
|
RU2553533C2 |
| RECOMBINANT PLASMID pET-15b_T1_RL DNA PROVIDING SYNTHESIS OF RECOMBINANT FUSION PROTEIN CONSISTING OF TUMOR-SPECIFIC PEPTIDES AND ANTITUMOR PEPTIDE RL2, AND RECOMBINANT FUSION PROTEIN POSSESSING CYTOTOXIC ACTIVITY AGAINST CANCER CELLS AND TARGETED PROPERTIES AGAINST TUMOR TISSUE | 2016 |
|
RU2619050C1 |
| METHOD OF PRODUCING RECOMBINANT Β-1,4-GALACTOSIDASE BGAA FROM STREPTOCOCCUS PNEUMONIAE | 2019 |
|
RU2698460C1 |
| RECOMBINANT PLASMID pET-15b_T3_RL DNA PROVIDING SYNTHESIS OF RECOMBINANT FUSION PROTEIN CONSISTING OF TUMOR-SPECIFIC PEPTIDES AND ANTITUMOR PEPTIDE RL2, AND RECOMBINANT FUSION PROTEIN POSSESSING ANTI-TUMOR ACTIVITY AGAINST HUMAN BREAST CANCER | 2016 |
|
RU2619053C1 |
| METHOD FOR LARGE-SCALE PRODUCTION, SEPARATION AND PURIFICATION OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR | 2010 |
|
RU2487885C2 |
| RECOMBINANT EL1 PEPTIDE HAVING CYTOTOXIC ACTIVITY RELATIVE TO HUMAN CANCER CELLS | 2017 |
|
RU2683221C1 |
| STRAIN OF Escherichia coli BACTERIA - PRODUCENT OF HEAT SHOCK PROTEIN 70 AND METHOD FOR OBTAINING PREPARATION OF HUMAN HEAT SHOCK PROTEIN | 2013 |
|
RU2564120C2 |
| METHOD FOR PRODUCING SERRATIA MARCESCENS RECOMBINANT ENDONUCLEASE | 2021 |
|
RU2795623C2 |
| METHOD FOR CLEANING RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR FOR MEDICAL USE | 2017 |
|
RU2683950C1 |
